Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. noninvasive ventilators
Show results for
Products
Services
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Noninvasive Ventilators Articles & Analysis

8 news found

Medimprove – A New Private Clinic For Lung Revalidation With FRI

Medimprove – A New Private Clinic For Lung Revalidation With FRI

To address the need for better chronic respiratory care, Prof De Backer, emeritus Professor Pulmonology at the University of Antwerp and Chairman of The board of FLUIDDA NV, has opened a private clinic in Belgium near the Fluidda headquarters in Kontich, Belgium. The clinic uses a multidisciplinary approach for chronic respiratory failure. Care at this private clinic can involve exercise ...

ByFluidda


Topline results from Phase 3 SPRINTER trial

Topline results from Phase 3 SPRINTER trial

Synairgen plc (LSE: SNG), the respiratory company developing SNG001, a formulation for inhalation containing the broad-spectrum antiviral protein interferon beta, today announces that the international Phase 3 SPRINTER trial of SNG001 in patients hospitalised with COVID-19 did not meet its primary or key secondary efficacy endpoints. SNG001 demonstrated a favourable safety profile and was well ...

BySynairgen plc


National Patient Safety Agency Alert Concerning Nebulisers

National Patient Safety Agency Alert Concerning Nebulisers

The National Patient Safety Agency recently issued an alert (NatPSA/2021/003/NHSPS) necessitating organisations to “purchase sufficient powered nebuliser devices for use across the organisation; to remove the need for medical air to drive nebulisers via a flowmeter”. It states that all NHS hospitals are required to be fully compliant by the 16th November 20211. Aerogen, vibrating ...

ByAerogen


Data from Eli Lilly’s COV-BARRIER trial shows baricitinib reduced deaths in hospitalised COVID-19 patients by 38%

Data from Eli Lilly’s COV-BARRIER trial shows baricitinib reduced deaths in hospitalised COVID-19 patients by 38%

The latest data published in Eli Lilly’s Phase 3 randomised, double-blind, placebo-controlled study (COV-BARRIER) shows the largest clinical effect reported to date for a reduction in mortality in the COVID-19 patient population. ‍ Early in the pandemic, BenevolentAI researchers identified Baricitinib as a potential treatment for COVID-19 and published the hypothesis in The Lancet ...

ByBenevolent


Signifier® Medical Technologies Announces Award of UK NHS Supply Chain Tender

Signifier® Medical Technologies Announces Award of UK NHS Supply Chain Tender

Signifier Medical Technologies (“Signifier” or “the Company”), an innovator in the sleep disordered breathing market, is pleased to announce the successful award of the UK Non-invasive Ventilation, Sleep Therapy and Sleep Monitoring Tender, which will confirm Signifier as an approved supplier to the UK’s National Health Service (NHS). This contract award gives ...

BySignifier Medical Technologies Ltd


TrillaMed Named Distributor of Respiratory Motion Minute Ventilation Monitor

TrillaMed Named Distributor of Respiratory Motion Minute Ventilation Monitor

Respiratory Motion Inc. (RMI) announced today it has signed a distribution agreement with TrillaMed for the U.S. Veteran Health Administration, Department of Defense and other government-based markets. Per the agreement, TrillaMed will work in conjunction with RMI’s direct field team to distribute the ExSpiron® minute ventilation monitor. ExSpiron is the only non-invasive minute ...

BySenzime AB Uppsala


Sommetrics and aerFree, LLC Contributing to Treatment of COVID-19

Sommetrics and aerFree, LLC Contributing to Treatment of COVID-19

VISTA, Calif. — MAY 13, 2020 — Sommetrics, Inc. a company providing products and services to improve sleep quality, and its partially owned affiliate, aerFree, LLC, which is dedicated to improving acute airway management, today announced the donation of their aerFree® product to leading academic centers to assist in the management of COVID-19 respiratory impairment. aerFree® ...

BySommetrics


FDA Grants ALung Emergency Use Authorization (EUA) to the ALung for the Treatment of COVID-19

FDA Grants ALung Emergency Use Authorization (EUA) to the ALung for the Treatment of COVID-19

Based on the information submitted, the FDA stated that it believes the Hemolung RAS has the potential to treat lung failure as an adjunct to noninvasive or invasive mechanical ventilation, to reduce hypercapnia and hypercapnic acidosis due to COVID-19, and/or to maintain normalized levels of partial pressure of carbon dioxide(PCO2) and pH in patients suffering ...

ByLivaNova PLC

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT